Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chen Shu, PhD
University of Alabama at Birmingham
Principal Investigator - Qingzhong Kong, PhD
Case Western Reserve University
Principal Investigator - Steven Gunzler, MD
University Hospitals Cleveland Medical Center and Case Western Reserve University
Principal Investigator - Zerui Wang, MD, PhD
Case Western Reserve University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- University Hospitals Suburban Health Center
South Euclid, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Mar 2019
- Primary completion
- 31 May 2025
- Completion
- 31 May 2025
- Last update posted
- 1 Jul 2025
- Registered enrollment
- 184
- Registry id
- NCT04518059
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.